Ningyu An
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ningyu An has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Liu
Medical Science Research Institution of Ningxia Hui Autonomous Region Medical Sci‐Tech Research Center of Ningxia Medical University Yinchuan Ningxia Hui Autonomous Region China
1 shared publication - Cuixia Yang
Department of Ophthalmology, People's Hospital of Ningxia Hui Autonomous Region The Third Affiliated Clinical College of Ningxia Medical University Yinchuan Ningxia Hui Autonomous Region China
1 shared publication - Qian Li
People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China
1 shared publication - Xiaomin Cui
Department of Ophthalmology, People's Hospital of Ningxia Hui Autonomous Region The Third Affiliated Clinical College of Ningxia Medical University Yinchuan Ningxia Hui Autonomous Region China
1 shared publication - Xiumei Ma
Department of Ophthalmology, People's Hospital of Ningxia Hui Autonomous Region The Third Affiliated Clinical College of Ningxia Medical University Yinchuan Ningxia Hui Autonomous Region China
1 shared publication - Yang Zheng
Department of Ophthalmology, People's Hospital of Ningxia Hui Autonomous Region The Third Affiliated Clinical College of Ningxia Medical University Yinchuan Ningxia Hui Autonomous Region China
1 shared publication
Latest Publications
- Open Access
- 28 May 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (5) , e1304
The circulating IL‐35+ regulatory B cells are associated with thyroid associated opthalmopathy
Background: Thyroid‐associated ophthalmopathy (TAO) is the most common orbital disease in adults, potentially leading to disfigurement and visual impairment. However, the causes of TAO are not fully understood. IL‐35+B cells are a newly identified regulatory B cells (Bregs) in maintaining immune balance in various autoimmune diseases. Yet, the influence of IL‐35+Bregs in TAO remains unexplored.Methods: This study enrolled 36 healthy individuals and 14 TAO patients. We isolated peripheral blood mononuclear cells and stimulated them with IL‐35 and CpG for 48 h. Flow cytometry was used to measure the percentages of IL‐35+Bregs.Results: The percentage of circulating IL‐35+Bregs was higher in TAO patients, and this increase correlated positively with disease activity. IL‐35 significantly increased the generation of IL‐35+Bregs in healthy individuals. However, B cells from TAO patients exhibited potential impairment in transitioning into IL‐35+Breg phenotype under IL‐35 stimulation.Conclusions: Our results suggest a potential role of IL‐35+Bregs in the development of TAO, opening new avenues for understanding disease mechanisms and developing therapeutic approaches.
- 28 May 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (5) , e1304
Open AccessThe circulating IL‐35+ regulatory B cells are associated with thyroid associated opthalmopathy
Background: Thyroid‐associated ophthalmopathy (TAO) is the most common orbital disease in adults, potentially leading to disfigurement and visual impairment. However, the causes of TAO are not fully understood. IL‐35+B cells are a newly identified regulatory B cells (Bregs) in maintaining immune balance in various autoimmune diseases. Yet, the influence of IL‐35+Bregs in TAO remains unexplored.Methods: This study enrolled 36 healthy individuals and 14 TAO patients. We isolated peripheral blood mononuclear cells and stimulated them with IL‐35 and CpG for 48 h. Flow cytometry was used to measure the percentages of IL‐35+Bregs.Results: The percentage of circulating IL‐35+Bregs was higher in TAO patients, and this increase correlated positively with disease activity. IL‐35 significantly increased the generation of IL‐35+Bregs in healthy individuals. However, B cells from TAO patients exhibited potential impairment in transitioning into IL‐35+Breg phenotype under IL‐35 stimulation.Conclusions: Our results suggest a potential role of IL‐35+Bregs in the development of TAO, opening new avenues for understanding disease mechanisms and developing therapeutic approaches.